Experience

Terns Pharmaceuticals
• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee
• Senior Vice President, Research

  • Dec 2021 - Present

Rubedo Life Sciences
• United States
• Biotechnology
• 1 - 100 Employee
• Vice President, Drug Discovery

  • Jan 2020 - Dec 2021

Merck
• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee
• Executive Director, Research Science

  • Jun 2017 - Jan 2020


REVOLUTION Medicines

• United States
• Biotechnology
• 100 - 200 Employee

• Vice President, Preclinical Sciences

  • Aug 2015 - May 2017

  Responsible for pharmacology, translational research and preclinical development. Responsible for pharmacology, translational research and preclinical development.



Altos Therapeutics

• United States
• Pharmaceutical Manufacturing

• Co-founder and consultant

  • 2011 - Mar 2017

  Co-founder and Consultant. Altos is a specialty pharmaceutical company devoted to identifying and developing compounds for gastrointestinal and associated disorders with high unmet medical need. Co-founder and Consultant. Altos is a specialty pharmaceutical company devoted to identifying and developing compounds for gastrointestinal and associated disorders with high unmet medical need.


ALDEA Pharma
• Biotechnology Research
• 1 - 100 Employee
• Senior Vice President, Pharmacology & Preclinical Development

  • Mar 2015 - Jul 2015


Cytokinetics

• United States
• Biotechnology Research
• 200 - 300 Employee

• Head of Pharmacology

  • Mar 2010 - Mar 2015

  Responsible for in vivo pharmacology and non-clinical safety/toxicology. Research focus on cardiac muscle activators and skeletal muscle activators; experience with neuromuscular/neurodegenerative diseases and aging models. Program leader for smooth muscle myosin inhibitor bronchodilator program. Member of Joint Research Committee with Astellas Pharmaceuticals for Fast Skeletal Troponin Activator Program. Responsible for in vivo pharmacology and non-clinical safety/toxicology. Research focus on cardiac muscle activators and skeletal muscle activators; experience with neuromuscular/neurodegenerative diseases and aging models. Program leader for smooth muscle myosin inhibitor bronchodilator program. Member of Joint Research Committee with Astellas Pharmaceuticals for Fast Skeletal Troponin Activator Program.



ARYx Therapeutics

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Director/Dept. Head, Pharmacology

  • 2006 - Nov 2009

  Interfaced with both Research and Development. As department head, was responsible for in vitro and in vivo pharmacology in-house as well as for design of experiments and coordination with CROs and interpretation of results for contracted research. Co-chair of the Portfolio Management Committee and substantial role in new program evaluation and initiation. Clinical project leader for the tecarfarin anticoagulant program (Phase II/III clinical trials) and preclinical leader for gastrointestinal program. Show less



Theravance

• Senior Director

  • 1999 - 2006

  Built the G-protein coupled receptor and molecular biology groups. Non-clinical project team leader for the overactive bladder program in clinical development. Additionally, helped initiate a novel COPD/asthma program (called MABA, now in Phase 3 clinical trials) and led the program in both research and clinical development; Member of the Joint Project Committee (JPC) for respiratory disease between Theravance and GSK to bridge Research and Development and ensure the rapid progression of the clinical programs. Show less



Roche Palo Alto

• Research Scientist

  • 1994 - 1999

  In vitro pharmacology research in urogenital, pain and cardiovascular areas. Program leader for one cardiovascular and two pain programs (also acted as both project leader and project manager for cardiovascular project in clinical development). In vitro pharmacology research in urogenital, pain and cardiovascular areas. Program leader for one cardiovascular and two pain programs (also acted as both project leader and project manager for cardiovascular project in clinical development).

• Sr. Research Pharmacologist

  • 1993 - 1994

  Led in vitro pharmacology research group in fields of preterm labor and cardiovascular disease. Led in vitro pharmacology research group in fields of preterm labor and cardiovascular disease.